Streetbeat News

Assets

DIN

Dine Brands forecasts its FY24 consolidated adjusted EBITDA to be between $255M-$265M, with gross capital expenditures estimated to range from $15M-$20M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:12 pm

MRSN

Mersana Therapeutics has announced that its current capital resources are expected to support its operating plan commitments into 2026. This indicates a stable financial outlook for the company, suggesting that it has sufficient funds to maintain its operations and pursue its strategic goals without the immediate need for additional capital.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:09 pm

NRG

NRG Energy has announced plans to increase its dividend per share by 7-9% annually, complete its $2.7 billion share repurchase authorization, and reduce its debt by up to $2.55 billion by the end of 2025.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:08 pm

GERN

Geron (NASDAQ:GERN) reported Q4 earnings with a loss of $(0.09) per share, beating the $(0.10) estimate. However, sales of $23K missed the $70K estimate significantly. The company has $378.1M in cash and equivalents, expected to fund operations into Q3 2025.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:08 pm

DHT

DHT Holdings has signed agreements to construct four very large crude carriers (VLCCs), with expected delivery dates ranging from April to December 2026. This move indicates DHT Holdings' strategic expansion in the crude oil transportation sector and its long-term commitment to enhancing its fleet capacity.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:55 am

GTHX

G1 Therapeutics reported ending 2023 with $82.2M in cash, cash equivalents, and marketable securities, projecting a cash runway into 2025.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:39 am

XTKG

X3 Holdings has entered into a term sheet for multi-year purchase agreements with a supplier to buy 30,000 Avalon Bitcoin miners by 2026, using cash and vendor credits. This move signifies X3 Holdings' commitment to expanding its Bitcoin mining capabilities.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:28 am

LFST

LifeStance Health Group, Inc. (LFST) forecasts its fiscal year 2024 revenues to be between $1.19B and $1.24B, aligning closely with the consensus estimate of $1.20B. The company also anticipates a center margin of $345M-$365M and an adjusted EBITDA of $80M-$90M, with expectations to generate positive free cash flow for the year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 11:16 am

BTCUSD

Financial expert Dave Ramsey warned against investing in assets without understanding them, specifically mentioning his preference for real estate and mutual funds. Despite not mentioning Bitcoin directly, BTC proponents on X suggested he consider it, highlighting its recent price surge to a 27-month high around $57,000. Ramsey has previously expressed skepticism towards cryptocurrencies, advising against them as investments.

Portfolio Pulse from Mehab Qureshi

February 28, 2024 | 11:10 am

DOGEUSD

ETHUSD

SHIBUSD

Shytoshi Kusama, the lead developer of Shiba Inu, expressed curiosity about the conspiracy theory-inducing murals at Denver Airport. His interest coincides with a 7.2% rise in Shiba Inu's price, amidst an altcoin season. Shiba Inu, a meme coin based on Ethereum, is part of the cryptocurrency trend alongside Dogecoin.

Portfolio Pulse from Benzinga Neuro

February 28, 2024 | 11:10 am